Bookmark

Add to MyYahoo RSS

Spectrum Pharmaceuticals News

News on Spectrum Pharmaceuticals (Ticker: SPPI) continually updated from thousands of sources around the net.

2 hrs ago | Biopharm

Spectrum Pharmaceuticals Appoints New President and COO

Spectrum Pharmaceuticals , a biotechnology company with a primary focus in hematology and oncology, has appointed Joseph Turgeon, previously senior vice president and COO, as president and COO, replacing Ken Keller.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Oncology

Wed Apr 23, 2014

Freshnews

Ligand's Partner Spectrum Pharmaceuticals Reports Captisol-Enabled...

Ligand Pharmaceuticals Incorporated announces that its Captisol-enabled Melphalan development and commercial partner Spectrum Pharmaceuticals has reported that their pivotal trial of CE Melphalan met its primary endpoint.

Comment?

Related Topix: Ligand Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Alkeran, Melphalan (generic), Healthcare Law, Law, Food and Drug Administration

Mon Apr 21, 2014

BioResearch Online

BioAlliance Pharma Acquires Biopharmaceutical Firm Topotarget

French pharmaceutical company BioAlliance Pharma has agreed to acquire the Scandinavian biopharmaceutical firm Topotarget.

Comment?

Related Topix: Oncology, Medicine, Lymphoma, Health, Biotech, Healthcare Industry

Hispanic Business

Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as...

'Joe was responsible for building a top sales organization and for launching four of the world's top-selling biologicals, during his over two decades at Amgen.

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Oncology, Hematology, Vincristine (generic), Oncovin, Vincasar

Fri Apr 18, 2014

Sys-Con Media

Ken Keller Named President, US Commercial, Daiichi Sankyo, Inc.

In his role, Mr. Keller will be responsible for leading marketing, sales, medical affairs and supply chain operations for Daiichi Sankyo in the U.S. , President and CEO of Daiichi Sankyo Co., Ltd., the parent company of the Daiichi Sankyo Group.

Comment?

Related Topix: Marketing, Biotech, Medicine, Healthcare Industry

Tue Apr 15, 2014

Sys-Con Media

Analysts View on Biotech Equities -- Research on Organovo Holdings,...

The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 648.05, up 0.51%, while the same has fallen by 1.86% in the previous three months.

Comment?

Related Topix: Startups, BioMarin Pharmaceutical, Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry, Vertex, Financial Markets

Tue Apr 08, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

In first quarter 2014, ... )--Government Properties Income Trust today announced its regular quarterly common share distribution of $0.43 per common share .

Comment?

Related Topix: Startups, Rambus, Inventions, Science / Technology, Biotech, Medicine, Healthcare Industry

Business Wire

View Press Release

If you own common stock in Spectrum Pharmaceuticals, Inc. and wish to obtain additional information, please contact Eduard Korsinsky, Esq.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, New York

MarketWatch

Stock market live blog: S&P 500 breaks 3-day skid; Google, Yahoo, eBay rally

Rajesh C. Shrotriya, chairman and chief executive of Spectrum Pharmaceuticals, says with conviction that a lot of biotech shares are overvalued because, simply put, they've been "selling a dream" instead of focusing on fundamentals.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

Mon Apr 07, 2014

AmericanBankingNews.com

Spectrum Pharmaceuticals Downgraded by TheStreet to "Sell"

The analysts wrote, "Spectrum Pharmaceuticals has been downgraded by TheStreet Ratings from hold to sell.

Comment?

Related Topix: Biotech, Healthcare Industry

Tue Apr 01, 2014

Bangor Daily News

Varney Agency hires Lee Rossignol, director of sales

Varney Agency is pleased to announce the hiring of Lee Rossignol, director of sales.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Sales, Marketing, University of Maine, Winslow, ME, Gorham, ME

Thu Mar 27, 2014

Hispanic Business

Topotarget announces financial results for the year ended Dec 31, 2013

A net loss in continued operations of ). Revenues are composed of milestone payments from the renegotiated agreement with Apricus Biosciences, Inc. and income per our collaboration agreement with Spectrum Pharmaceuticals.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Mar 26, 2014

GlobeNewswire

Topotarget confirms receipt of acceptance-to-file milestone payment

Topotarget A/S hereby confirms the receipt of the milestone payment of USD 10 million and 1 million shares from Spectrum Pharmaceuticals, Inc. related to the US Food and Drug Administration's recent acceptance to file BeleodaqTM for peripheral T-cell lymphoma .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Lymphoma, Health, Oncology, Sarcoma

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••